Skip to main content
. 2022 May 19;17(13):e202200002. doi: 10.1002/cmdc.202200002

Figure 4.

Figure 4

a‐d) Treatment with G9a inhibitors ameliorates motor dysfunction of CL2006 worms. For dose‐response: Values represented are mean ± Standard error of the mean (SEM); n=3 with at least 90–100 worms in each group. Statistical analysis: One‐Way ANOVA, followed by Dunnett post‐hoc analysis. 0 μM Vs. UNC0638 treatment: ***p<0.001; ****p<0.0001. 0 μM Vs. new G9a inhibitor treatment: #p<0.05; ##p<0.01; ###p<0.001; ####p<0.0001.